The Claim

Launched new studies to more closely examine autism.

The Claim, Unpacked

What is literally being asserted?

The administration initiated research studies that investigate autism in greater depth than prior efforts.

What is being implied but not asserted?

The vague phrasing — “more closely examine” — implies the government is doing something no previous administration bothered to do: taking a serious look at what causes autism. The word “closely” insinuates that prior research was insufficiently rigorous or avoided asking the hard questions. In the context of RFK Jr.’s long-standing vaccine-autism advocacy, “more closely examine” serves as a coded signal that the administration is investigating the specific causal theories (vaccines, environmental exposures) that the scientific mainstream has studied extensively and found unsupported.

What is conspicuously absent?

Any specificity whatsoever. No study names, no funding amounts, no research institutions, no timelines, no research questions. This is the vaguest possible restatement of item 311, which at least names the $50 million figure and the data science focus. The vagueness obscures that the administration simultaneously cut $80 million in existing autism research, directed the CDC to alter its website to cast doubt on the vaccine-autism scientific consensus, contracted a sole-source vaccine-autism study to Rensselaer Polytechnic Institute, and restructured the federal autism advisory committee with vaccine skeptics.

Padding Analysis: Vaguer Restatement of Item 311

This item is padding of item 311 (“Launched a $50 million autism data science initiative to unlock causes and improve outcomes”). Both items refer to the same set of actions: the NIH Autism Data Science Initiative (ADSI) announced September 22, 2025, and the broader autism research actions taken by the Trump administration in 2025. Item 311 provides the specifics ($50 million, data science initiative, 13 projects); item 318 strips those details to produce a second, vaguer line item from the same underlying activity.

The only way item 318 could be considered distinct from 311 is if it also encompasses the CDC’s sole-source contract with Rensselaer Polytechnic Institute to “investigate the association between vaccination and autism prevalence” (announced September 12, 2025) or the restructuring of the Interagency Autism Coordinating Committee (IACC) with vaccine-skeptic appointees. But those actions are not “studies” in any conventional scientific sense, and their inclusion would make the claim more problematic, not less.

Evidence Assessment

Established Facts

The primary “new studies” are the 13 ADSI projects totaling $50 million, already counted in item 311. [^318-a1] These projects, announced September 22, 2025, at major research institutions, examine gene-environment interactions, exposomics, and outcomes research. They represent the same initiative described in item 311 using different words.

The administration also directed the CDC to fund a sole-source contract with Rensselaer Polytechnic Institute to investigate the association between vaccination and autism prevalence. [^318-a2] Announced September 12, 2025, this contract bypassed competitive bidding to commission research into a question that the scientific consensus considers resolved. The CDC’s own prior research — and more than 50 studies covering over 15 million children — has found no causal link between vaccines and autism.

NIH spent approximately $306 million on autism research in FY2023, funding hundreds of existing studies across multiple institutes. [^318-a3] Autism research at NIH has been ongoing since at least 2000, with annual spending more than doubling since the mid-2000s. The Autism Centers of Excellence (ACE) program has funded large-scale multidisciplinary studies since 2007. The claim that these are “new studies to more closely examine autism” obscures the massive existing research portfolio.

The administration cut approximately $80 million in existing autism research prior to launching its new initiatives. [^318-a4] DOGE-driven budget cuts eliminated research across NSF, CDC, and NIH, including projects studying precisely the environmental causes that the new initiative purports to address.

Strong Inferences

The phrase “more closely examine” reflects RFK Jr.’s framing that prior autism research failed to ask the right questions, particularly about vaccines and environmental triggers. [^318-a5] Kennedy has repeatedly characterized autism as an “epidemic” and vowed to “end” it — framing that conflicts with the scientific understanding that increasing prevalence largely reflects broadened diagnostic criteria, expanded surveillance, and reduced stigma. The IACC was restructured in January 2026 with appointees aligned with Kennedy’s vaccine-autism views, including Daniel Rossignol, Ginger Taylor, and Toby Rogers. By March 2026, the reconstituted IACC canceled its first public meeting, and prominent autism researchers formed an Independent Autism Coordinating Committee (I-ACC) as an alternative.

The Rensselaer sole-source contract represents not conventional research but an effort to produce government-commissioned evidence for a predetermined conclusion. [^318-a6] Sole-source contracts bypass competitive peer review. The scientific question being investigated — whether vaccines cause autism — has been addressed by decades of research involving millions of subjects. Commissioning new research into a resolved question via non-competitive procurement signals that the goal is to produce a desired finding rather than to advance scientific knowledge.

What the Evidence Shows

Item 318 is a vaguer restatement of item 311. Both items describe the same underlying actions: the administration’s autism research initiatives launched in 2025, centered on the ADSI and the broader September 22 autism event. The only distinction is that item 318 strips away all specifics, leaving a claim so vague it could encompass anything from the legitimate ADSI-funded research to the scientifically dubious Rensselaer vaccine-autism contract.

The vagueness is itself revealing. “Launched new studies to more closely examine autism” is the kind of language that sounds reasonable on its face but carries a specific subtext in the context of an administration led by an HHS Secretary who has spent decades promoting the debunked claim that vaccines cause autism. “More closely examine” implies that prior research was negligent or evasive — when in fact the NIH has funded hundreds of millions of dollars in autism research annually, the CDC has operated the ADDM surveillance network since 2000, and the scientific literature contains thousands of peer-reviewed autism studies.

The administration did launch new autism research. It also cut more in existing autism research than it added, directed the CDC to undermine the scientific consensus on vaccines and autism, bypassed competitive procurement to commission a vaccine-autism study, and restructured the federal autism advisory committee with individuals who share Kennedy’s discredited views. The claim presents one line of a much longer and more troubling ledger.

The Bottom Line

This is padding. Item 311 already claimed credit for the $50 million autism data science initiative; item 318 restates the same activity in vaguer terms to generate a second entry on the “365 wins” list. The underlying actions are real but already counted. To the extent item 318 also encompasses the Rensselaer vaccine-autism contract and IACC restructuring, these are actions that the scientific community has broadly condemned as politically motivated. The administration launched some new autism studies, but it also defunded more existing ones than it created, and the framing of “more closely examine” reflects an HHS Secretary’s discredited conviction that mainstream science missed the answers he has been promoting for two decades.